Vivimed Labs Share Price Today | Stock Price & Vivimed Labs Share Screener

Track the current stock price of Vivimed Labs with an interactive chart. Analyse VIVIMEDLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vivimed Labs stock quote in one place.

The quote of ₹7.63 sits between the 52-week low of ₹5.28 and the 52-week high of ₹26.60, and the latest session moved 4.38% from the previous close.

Screen Vivimed Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VIVIMEDLAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE526G01021.

Classification

Identifiers and Leadership

Screen VIVIMEDLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹754, down from ₹921 in 2025.

Latest statistics put total assets at ₹754 and shareholder funds at ₹-211.

Screen Vivimed Labs income statement and profit fundamentals. Analyze VIVIMEDLAB quarterly results. Vivimed Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹18 and net profit was ₹-147, equal to earnings per unit of ₹-17.24, at an operating margin of -1169%.

In that period expenses were ₹152, interest cost ₹1 and tax ₹0. The next period listed, 2025-Dec, shows revenue of ₹16 and net profit of ₹-17.

Screen VIVIMEDLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities used ₹2, and net cash flow was an outflow of ₹1.

Over the same period, investing activities used ₹5 and financing activities provided ₹5.

See Vivimed Labs shareholding pattern with promoter, FII, and DII holdings. Check Vivimed Labs promoter holding and ownership changes for VIVIMEDLAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 7.57%, foreign institutions 1.64%, domestic institutions 0.00% and the public 68.75%, spread across 47,492 shareholders.

The shareholder count was 47,492 in 2026-Mar, compared with 49,221 in 2025-Dec.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vivimed Labs. Vivimed Labs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

See which indices include Vivimed Labs stock. Check VIVIMEDLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Vivimed Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vivimed Labs stock events that may affect VIVIMEDLAB share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 17, 2026, with a record date of July 17, 2026.

It is followed by Quarterly Result Announcement dated May 30, 2026 and Quarterly Result Announcement dated March 13, 2026.

Screen VIVIMEDLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen VIVIMEDLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 27, 2026.

The next most recent announcements are dated September 27, 2026 and September 23, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.